Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Conventional vs Dose Intensive Temozolomide in Glioblastoma
NCT01364064Phase 3Completed
- Sponsor
- King Faisal Specialist Hospital and Research Centre
- Start
- Jan 2007
- Primary completion
- Jun 2008
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of temozolomide in glioblastoma (GBM), sponsored by King Faisal Specialist Hospital and Research Centre. Started Jan 2007; status: completed.
02
Drugs
temozolomide
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on NCT01364064.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01364064.